How much funding has BioAge Labs raised?

BioAge Labs has raised $170.0M in total funding, most recently a Series D round.

Who are BioAge Labs's investors?

BioAge Labs's investors include Sofinnova Investments, Andreessen Horowitz.

When was BioAge Labs founded?

BioAge Labs was founded in 2015.

Where is BioAge Labs headquartered?

BioAge Labs is headquartered in San Francisco Bay Area, California, United States.

What industry is BioAge Labs in?

BioAge Labs operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does BioAge Labs have?

BioAge Labs has 51-200 employees.

BioAge Labs

IPO

Harnessing aging to transform health

Public · San Francisco Bay Area, United States · Founded 2015 · $170.0M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: San Francisco Bay Area, California
Employees: 51–200
Founded: 2015
Business Model: Other
Website: bioagelabs.com

Total Funding: $170.0M
Last Round: $170.0M Series DFeb 2024
Rounds: 1
Type: Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

BioAge Labs harnesses the biology of human aging to develop therapies for metabolic diseases like obesity and cardiovascular issues. Their pipeline features BGE-102, an NLRP3 inhibitor for inflammation, and an APJ agonist mimicking exercise effects, discovered via a human-first multi-omics platform.

Summary

BioAge Labs is an Artificial Intelligence company based in San Francisco Bay Area, United States, founded in 2015. It has raised $170.0M in total across 1 round, most recently a $170.0M Series D round in Feb 2024. Investors include Sofinnova Investments and Andreessen Horowitz.

LinkedIn X (Twitter)

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DFeb 2024

$170.0M

Feb 2024

Investors

Sofinnova Investments

Lead

1 round

Andreessen Horowitz

1 round

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare

Growth Equity·$5.1B·Aug 2022

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare

Private Equity·$3.9B·Jan 2019

Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare

Series F·$3.8B·Jan 2026

IVI-RMA

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Valencia, Spain5001–10000Biotech, Healthcare

Private Equity·$3.3B·Apr 2022

inVentiv HealthAcquired

inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...

Burlington, United States5001–10000Biotech, Healthcare

Private Equity·$3.0B·May 2017

Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare

Private Equity·$3.0B·Jan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

<a href="https://indexed.vc/companies/bioage-labs"><img src="https://indexed.vc/api/badge/company/bioage-labs" alt="BioAge Labs on Indexed.vc" width="260" height="76" /></a>